IDEXX LABORATORIES, INC.

(IDXX)
  Report
Real-time Estimate Cboe BZX  -  10:34 2022-08-09 am EDT
397.48 USD   -2.34%
09:24aWALL STREET STOCK EXCHANGE : Calm prevails ahead of inflation data
MS
05:25aANALYST RECOMMENDATIONS : Nvidia, Nike, Linde, Republic Services, Idexx Laboratories...
MS
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Idexx: 2Q Earnings Snapshot

07/31/2020 | 06:42am EDT

WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported second-quarter profit of $148.9 million.

On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.72.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.20 per share.

The Animal diagnostic and health care company posted revenue of $637.6 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $580 million.

Idexx shares have risen 43% since the beginning of the year. The stock has risen 31% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IDXX at https://www.zacks.com/ap/IDXX

Automated Insights, source Associated Press News

All news about IDEXX LABORATORIES, INC.
09:24aWALL STREET STOCK EXCHANGE : Calm prevails ahead of inflation data
MS
05:25aANALYST RECOMMENDATIONS : Nvidia, Nike, Linde, Republic Services, Idexx Laboratories...
MS
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates ..
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overw..
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Over..
MT
08/03Atlantic Equities Adjusts Price Target on IDEXX Laboratories to $490 From $500, Reitera..
MT
08/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
08/02WALL STREET STOCK EXCHANGE : Pelosi’s expected Taiwan visit spooks markets
MS
08/02SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Tuesday
MT
08/02TRANSCRIPT : IDEXX Laboratories, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 382 M - -
Net income 2022 687 M - -
Net Debt 2022 1 126 M - -
P/E ratio 2022 50,3x
Yield 2022 -
Capitalization 34 191 M 34 191 M -
EV / Sales 2022 10,4x
EV / Sales 2023 9,55x
Nbr of Employees 10 350
Free-Float 77,1%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 407,00 $
Average target price 477,00 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-38.07%34 191
ABBOTT LABORATORIES-22.37%190 883
MEDTRONIC PLC-9.83%124 341
STRYKER CORPORATION-18.73%82 217
BECTON, DICKINSON AND COMPANY4.15%73 001
HOYA CORPORATION-15.34%38 786